/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Pharmaceutical preparations company · DE · FY ends Dec · Revenue $158M · -80.76% margin · -$104M FCF
The business is unprofitable at the operating level (-80.76% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 20.6% YoY with margins expanding 84.9pp.
Negative free cash flow of -$104M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$158M
▲ +20.6% YoY
Net Income (TTM)
-$107.32B
▼ -12.4% YoY
Op. Margin
-80.76%
▲ +84.9pp YoY
ROIC
-21.26%
▲ +19.0pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$104M
▼ -29.6% YoY
Op. Cash Flow (TTM)
-$104M
▼ -32.8% YoY
Net Debt
-$438M
Net Cash Position
Cash & Equiv.
$441M
Continue Research
SourceComputed from the 10-Q filed 24 Feb 2026, covering the period ending 31 Dec 2025, as reported to the SEC. Data last refreshed 24 Feb 2026. How this is calculated.
Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.